pharmaboardroom.com
Open in
urlscan Pro
35.189.116.82
Public Scan
Submitted URL: http://pharmaboardroom.com/
Effective URL: https://pharmaboardroom.com/
Submission: On April 05 via manual from SG — Scanned from GB
Effective URL: https://pharmaboardroom.com/
Submission: On April 05 via manual from SG — Scanned from GB
Form analysis 2 forms found in the DOM
GET https://pharmaboardroom.com/
<form id="header_search_form" action="https://pharmaboardroom.com/" role="search" method="get" class="form-inline my-2 my-lg-0 search-form" data-hs-cf-bound="true">
<div class="center-search d-flex align-items-center justify-content-center bd-highlight mb-3">
<span class="screen-reader-text">Search for:</span>
<input class="form-control mr-sm-2 search-form__input" id="search-bar" type="search" data-swplive="true" title="Search for:" value="" name="s"
aria-label="When autocomplete results are available use up and down arrows to review and enter to go to the desired page. Touch device users, explore by touch or with swipe gestures." placeholder="Search" autocomplete="off"
aria-owns="searchwp_live_search_results_624bc9dfd7723" aria-autocomplete="both">
<button class="btn nav-btn search-form__submit">
<i class="fa fa-search"></i>
</button>
</div>
</form>POST login
<form action="login" method="post" data-hs-cf-bound="true">
<fieldset>
<label for="username" class="sr-only">Username</label>
<input id="username" type="text" name="username" placeholder="Username">
<label for="password" class="sr-only">Password</label>
<input id="password" type="password" name="password" placeholder="Password">
<button class="btnc btnc--pill salmon large follow-off" name="submit">Sign in </button>
<p class="status"></p>
<div>
<a href="https://pharmaboardroom.com/login?action=forgot_password" class="lost mp-text-link">Forgot password?</a>
</div>
<div>
<a href="https://pharmaboardroom.com/register/member/" class="lost mp-text-link">No Account? Register Now.</a>
</div>
</fieldset>
<input type="hidden" id="security" name="security" value="3b5067dc47"><input type="hidden" name="_wp_http_referer" value="/"> <input type="hidden" id="redirect-after-login" value="https://pharmaboardroom.com/">
</form>Text Content
WE VALUE YOUR PRIVACY We and our partners store and/or access information on a device, such as cookies and process personal data, such as unique identifiers and standard information sent by a device for personalised ads and content, ad and content measurement, and audience insights, as well as to develop and improve products. With your permission we and our partners may use precise geolocation data and identification through device scanning. You may click to consent to our and our partners’ processing as described above. Alternatively you may access more detailed information and change your preferences before consenting or to refuse consenting. Please note that some processing of your personal data may not require your consent, but you have a right to object to such processing. Your preferences will apply to this website only. You can change your preferences at any time by returning to this site or visit our privacy policy. MORE OPTIONSAGREE Search for: * Sign in * Register * Country Reports * Interviews * InFocus * Europe * Asia-Pacific * Americas * Middle East & Africa * Legal & Regulatory * Facts & Figures * Library * Op-eds * Shop Sign In Register * Country Reports * Interviews * InFocus * Europe * Asia-Pacific * Americas * Middle East & Africa * Legal & Regulatory * Facts & Figures * Library * Op-eds * Shop TOP STORIES EUROPE / EMA’S ANA HIDALGO-SIMON ON FIVE ADVANCED THERAPY TRENDS In an extensive recent PharmaBoardroom conversation, EMA Head of Advanced Therapies Ana-Hidalgo-Simon highlighted some of the most important trends around advanced therapy regulation in Europe. Hidalgo-Simon touched on why moderate growth in regulatory applications is a positive development for the… Save Share JAPAN / KIRIN LOOKS BEYOND BEER; SANOFI RARE DISEASE APPROVAL; JAPANESE COVID VACCINES INCOMING A roundup of the latest news from Japanese pharma, including Kirin’s USD 870 million investment in its healthcare and pharmaceuticals businesses over the next three years, Sanofi’s world-first approval for… Save Share GCC / SANOFI'S FOKION SINIS ON THE FUTURE OF VACCINES POST-COVID Fokion Sinis, Sanofi Vaccines’ General Manager for the Greater Gulf Multi Country Organisation, outlines some of the key impacts that the COVID-19 pandemic has had on the vaccine industry, the… Save Share MALAYSIA / MARKETING, MANUFACTURING, PACKAGING & LABELING, ADVERTISING OVERVIEW All about marketing, manufacturing, packaging & labeling, advertising in Malaysian Pharma. Prepared in association with Skrine, a leading law firm in Malaysia, this is an extract from The Pharma Legal Handbook:… Save Share CHINA / FILL, FINISH & BEYOND: THE CHINESE VACCINE DEVELOPERS EXPORTING THEIR AMBITIONS OVERSEAS Bridge Consulting’s Zoe Leung examines the journeys of Chinese-developed COVID-19 vaccines outside of China’s borders, drawing on a number of examples, from Sinopharm’s work on boosting vaccine supply in the… Save Share USA / PHRMA CHAIR ON WHAT HEALTH EQUITY MEANS TO BIOPHARMA Ramona Sequeira, recently appointed chair of the PhRMA board of directors and president of Takeda’s US Business Unit and Global Portfolio Commercialization, gives her take on how the biopharma industry… Save Share CEO PROFILE / ESTEVE’S STAFFAN SCHÜBERG ON MID-CAP INNOVATION, GENERICS DIVESTMENT & GROWTH FOUNDATIONS Way before securing the CEO role at Esteve in 2018, Staffan Schüberg built a career that saw him rise through the ranks of Lundbeck, from commercial activities in Sweden to… Save Share See more... LATEST REPORTS Download Download Download Download More Reports IN CONVERSATION MARGARITA ALFONSEL – GENERAL SECRETARY, SPANISH FEDERATION OF HEALTHCARE TECHNOLOGY COMPANIES (FENIN) Margarita Alfonsel, general secretary of Fenin, the Spanish Federation of Healthcare Technology Companies, reflects on the COVID-19 pandemic, the changing dynamics of the medical technology industry in Spain, and comments on key policy changes that Fenin’s members are advocating for. The pandemic has put [the medtech] sector in the spotlight, and we have shown that we are an innovative… Save Share CARLES FÀBREGA – MANAGING DIRECTOR HUMAN HEALTH,… HIPRA is a world-leading animal health company that has launched a record 22 animal vaccines in the last 10 years.… Save Share ANA HIDALGO-SIMON – HEAD OF ADVANCED THERAPIES,… Speaking exclusively to PharmaBoardroom, the EMA’s Head of Advanced Therapies Ana Hidalgo-Simon discusses steadily growing numbers of regulatory applications in… Save Share See more... FOCUS ON EUROPEAN BIOTECH VALL D’HEBRON: A ONE-STOP-SHOP FOR BREAKTHROUGH INNOVATION… Soon after reaching its 60th anniversary, in 2015, the largest hospital in Catalonia and a group of sister institutions began working on the creation of a new type of campus.… Save Share FIVE KEY TRENDS IN EUROPEAN PHARMA INNOVATION At the recent FT webinar, ‘Supporting Pharma Innovation in Europe’, high-level representatives from Roche, Bayer, and the European Commission weighed in on how European pharma’s competitive position on innovation is… Save Share EUROPEAN BIOTECH ROUNDUP: BIONTECH & CUREVAC DEAL TO… A roundup of the latest news from European biotech, including BioNTech and CureVac’s German vaccine manufacturing deal; the revival of Valneva’s plans to manufacture its vaccine in Scotland; and Morphosys’… Save Share LUCA BENATTI OF ERYDEL ON THE CHALLENGES OF… Luca Benatti, one of Italian biotech’s most notable entrepreneurs, outlines some of the key challenges of starting a biotech company in Europe, highlights how these barriers can be overcome, and… Save Share READ MORE: EUROPEAN BIOTECH >> FOCUS ON VACCINES MODERNA’S ENTRY INTO AFRICAN BIOTECH STRENGTHENS THE… Medicines for Africa's Lenias Hwenda examines the significance of Moderna's USD 500 million investment into African manufacturing, other agreements in place to boost manufacturing capacity on the continent, and why… Save Share FILL, FINISH & BEYOND: THE CHINESE VACCINE DEVELOPERS… Bridge Consulting’s Zoe Leung examines the journeys of Chinese-developed COVID-19 vaccines outside of China’s borders, drawing on a number of examples, from Sinopharm’s work on boosting vaccine supply in the… Save Share OVER A BILLION COVID-19 VACCINE DOSES: HOW DID INDIA DO IT? Writing in the March 2022 edition of DIA’s Global Forum magazine, Ananya Chakraborty from the Vydehi Institute of Medical Sciences & Research Centre outlines the key factors behind India’s successful… Save Share LATIN AMERICA PHARMA ROUNDUP: NEW MODERNA COMMERCIALISATION… The latest from Latin American pharma, including Moderna’s push to build a regional presence and partnership network; Pfizer’s health equity challenges in the region; and Brazil’s local manufacturing of AstraZeneca’s… Save Share READ MORE: VACCINES >> FOCUS ON SPAIN SPANISH PHARMA: 5 KEY INDUSTRY TRENDS 2021 According to recent IQVIA and industry association reports, the Spanish pharma market, valued at EUR 21.6 billion per year, continues to grow at a relatively slow pace. Other key trends… Save Share VALL D’HEBRON: A ONE-STOP-SHOP FOR BREAKTHROUGH INNOVATION… Soon after reaching its 60th anniversary, in 2015, the largest hospital in Catalonia and a group of sister institutions began working on the creation of a new type of campus.… Save Share SPAIN: AUTHORITIES COLLIDE OVER “FLU-IZATION” OF COVID As Spain’s Prime Minister, Pedro Sanchez, became the latest leader to call for COVID-19 to be treated as an endemic illness like the flu, regional health authorities warn that it… Save Share ESTEVE’S STAFFAN SCHÜBERG ON MID-CAP INNOVATION, GENERICS… Way before securing the CEO role at Esteve in 2018, Staffan Schüberg built a career that saw him rise through the ranks of Lundbeck, from commercial activities in Sweden to… Save Share READ MORE: SPAIN >> FOCUS ON USA ONCOLOGY: RIPE FOR DECENTRALISED RESEARCH Writing in the February edition of DIA’s Global Forum magazine, Candice Del Rio of Curavit Clinical Research examines the applicability of decentralised clinical trials in oncology research, and their positive… Save Share PHRMA’S FIRST EVER FEMALE BOARD CHAIR LOOKS TO STRIKE… Ramona Sequeira of Takeda has taken the reins as chair of US industry lobby group PhRMA’s Board of Directors, becoming the first ever woman to hold the role. She succeeds… Save Share AAM’S ACCESS! 2022: FIVE KEY US GENERIC & BIOSIMILAR… In the wake of Access! 2022, the Association for Accessible Medicines (AAM)’s first in-person annual summit in two years, AAM President and CEO Dan Leonard gives his five takeaways from… Save Share US FDA CDER NEW DRUG APPROVALS 2021 A comprehensive list of the US FDA’s Center for Drug Evaluation & Research (CDER)'s new drug therapy approvals for 2021. CDER approved 50 new drugs in 2021, down from 53… Save Share READ MORE: USA >> FOCUS ON CELL & GENE THERAPY CAR-T PATIENT ENGAGEMENT ROUNDTABLE: A VARIED GLOBAL PICTURE As complex cutting-edge therapies come online, industry sponsors are increasingly looking to engage with patients, caregivers, and advocacy groups earlier and more broadly in the drug development process to better… Save Share EMA’S ANA HIDALGO-SIMON ON FIVE ADVANCED THERAPY TRENDS IN… In an extensive recent PharmaBoardroom conversation, EMA Head of Advanced Therapies Ana-Hidalgo-Simon highlighted some of the most important trends around advanced therapy regulation in Europe. Hidalgo-Simon touched on why moderate… Save Share CAR-T AND THE ART OF MANAGING EXPECTATIONS Chimeric antigen receptor (CAR-T) therapy was first approved by the US FDA back in 2017 amid a great deal of fanfare and high expectations among patients about its potential as… Save Share RENDERING CELL & GENE THERAPY GENUINELY PATIENT CENTRIC In recent years, the much-discussed concept of “patient centricity” has been top-of-mind across all corners of the pharma industry. This is especially pertinent now that many innovative drug makers are… Save Share READ MORE: CELL & GENE THERAPY >> FOCUS ON ITALY ITALIAN BIOTECH: SOARING R&D SPEND & POST-COVID… Speaking recently to PharmaBoardoom, Assobiotec’s Leonardo Vingiani introduced the key dynamics shaping the Italian biotech industry today and the issues it still has to overcome to become truly globally competitive.… Save Share TOP 10 GLOBAL PHARMA MARKETS RANKING Based on IQVIA’s pharma market rankings for 2020, we give a rundown of the global top 10, key companies, important trends, and where you can go to learn more. … Save Share CLINICAL TRIALS IN ITALY: FOUR PHARMA COUNTRY MANAGERS HAVE… Italy is a key destination for global clinical trial programs with EUR 700 million invested in 2020 alone according to national industry association Farmindustria, bringing access to medicines, knowledge, skills,… Save Share GILEAD’S REMDESIVIR: FLEXIBLE PANDEMIC ACCESS AGREEMENTS… Less than two months passed between the WHO’s official pandemic declaration and remdesivir’s emergency use authorisation in the United States in May 2020. Today, the intravenous antiviral, sold by Gilead… Save Share READ MORE: ITALY >> FOCUS ON MEA MODERNA’S ENTRY INTO AFRICAN BIOTECH STRENGTHENS THE… Medicines for Africa's Lenias Hwenda examines the significance of Moderna's USD 500 million investment into African manufacturing, other agreements in place to boost manufacturing capacity on the continent, and why… Save Share AN ASSESSMENT OF REGULATORY SUBMISSIONS IN EAST & WEST… In the February edition of DIA’s Global Forum magazine Sybil Nana Ama Ossei-Agyeman-Yeboah of the West African Health Organization, Jane H. Mashingia from the East African Community Medicines Regulatory Harmonization… Save Share FIVE KEY TRENDS IN MEA MEDTECH The Middle East and Africa (MEA) medtech market is expected to grow from a value of USD 16.6 billion in 2019 to USD 21.8 billion at a CAGR of 3.6… Save Share WOMEN IN MEA MEDTECH: BEYOND DIVERSIFICATION TOWARDS A… On International Women’s Day 2022, Inna Nadelwais, executive director at Middle East and Africa medtech trade association Mecomed, examines the road still to travel towards true gender parity in the… Save Share READ MORE: MEA >> We use cookies to ensure that we give you the best experience on our site. For more info See our Cookie Privacy Policy Here Accept PHARMABOARDROOM * About us * Media Kit LEGAL & PRIVACY * Terms and Conditions * Privacy and Cookies policy CONTACT US +44 2078673717 info@pharmaboardroom.com For media inquiries, please contact: media@pharmaboardroom.com Address: PharmaBoardroom Limited Lynton House 7-12 Tavistock Square London, WC1H 9LT UK SUBSCRIBE Email Newsletters SOCIAL MEDIA × SIGN IN Username Password Sign in Forgot password? No Account? Register Now.